ASSERTIO SPECIALTY PHARMA
Live / Allowed — Notice of allowance issued (as of 11 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99084151
- Mark type
- Stylized text
- Filed
- 14 Mar 2025
- Published for opposition
- 16 Sept 2025
- Attorney of record
- Tim Burgdorf
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and management of central nervous system diseases and disorders and neurological disorders; Pharmaceutical preparations for the relief, treatment or amelioration of pain; Analgesic preparations; Anti-inflammatories; Pharmaceutical preparations, namely, drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents
Owner
- Assertio Therapeutics, Inc., Lake Forest, IL, US
- Assertio Therapeutics, Inc., Lake Forest, IL, US
Prior registrations
Prosecution history
- 11 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Sept 2025 — PUBLISHED FOR OPPOSITION
- 10 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Aug 2025 — EXAMINER'S AMENDMENT ENTERED
- 19 Aug 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 19 Aug 2025 — EXAMINERS AMENDMENT E-MAILED
- 19 Aug 2025 — EXAMINERS AMENDMENT -WRITTEN
- 14 Aug 2025 — ASSIGNED TO EXAMINER
- 14 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 14 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Mar 2025 — NEW APPLICATION ENTERED